Show simple item record

dc.contributor.authorGibbons, C
dc.contributor.authorPorter, I
dc.contributor.authorGonçalves-Bradley, DC
dc.contributor.authorStoilov, S
dc.contributor.authorRicci-Cabello, I
dc.contributor.authorTsangaris, E
dc.contributor.authorGangannagaripalli, J
dc.contributor.authorDavey, A
dc.contributor.authorGibbons, EJ
dc.contributor.authorKotzeva, A
dc.contributor.authorEvans, J
dc.contributor.authorvan der Wees, PJ
dc.contributor.authorKontopantelis, E
dc.contributor.authorGreenhalgh, J
dc.contributor.authorBower, P
dc.contributor.authorAlonso, J
dc.contributor.authorValderas, JM
dc.date.accessioned2021-10-18T11:22:19Z
dc.date.issued2021-10-12
dc.description.abstractBACKGROUND: Patient-reported outcomes measures (PROMs) assess a patient's subjective appraisal of health outcomes from their own perspective. Despite hypothesised benefits that feedback  on PROMs can support decision-making in clinical practice and improve outcomes, there is uncertainty surrounding the effectiveness of PROMs feedback. OBJECTIVES: To assess the effects of PROMs feedback to patients, or healthcare workers, or both on patient-reported health outcomes and processes of care. SEARCH METHODS: We searched MEDLINE, Embase, CENTRAL, two other databases and two clinical trial registries on 5 October 2020. We searched grey literature and consulted experts in the field. SELECTION CRITERIA: Two review authors independently screened and selected studies for inclusion. We included randomised trials directly comparing the effects on outcomes and processes of care of PROMs feedback to healthcare professionals and patients, or both with the impact of not providing such information. DATA COLLECTION AND ANALYSIS: Two groups of two authors independently extracted data from the included studies and evaluated study quality. We followed standard methodological procedures expected by Cochrane and EPOC. We used the GRADE approach to assess the certainty of the evidence. We conducted meta-analyses of the results where possible. MAIN RESULTS: We identified 116 randomised trials which assessed the effectiveness of PROMs feedback in improving processes or outcomes of care, or both in a broad range of disciplines including psychiatry, primary care, and oncology. Studies were conducted across diverse ambulatory primary and secondary care settings in North America, Europe and Australasia. A total of 49,785 patients were included across all the studies. The certainty of the evidence varied between very low and moderate. Many of the studies included in the review were at risk of performance and detection bias. The evidence suggests moderate certainty that PROMs feedback probably improves quality of life (standardised mean difference (SMD) 0.15, 95% confidence interval (CI) 0.05 to 0.26; 11 studies; 2687 participants), and leads to an increase in patient-physician communication (SMD 0.36, 95% CI 0.21 to 0.52; 5 studies; 658 participants), diagnosis and notation (risk ratio (RR) 1.73, 95% CI 1.44 to 2.08; 21 studies; 7223 participants), and disease control (RR 1.25, 95% CI 1.10 to 1.41; 14 studies; 2806 participants). The intervention probably makes little or no difference for general health perceptions (SMD 0.04, 95% CI -0.17 to 0.24; 2 studies, 552 participants; low-certainty evidence), social functioning (SMD 0.02, 95% CI -0.06 to 0.09; 15 studies; 2632 participants; moderate-certainty evidence), and pain (SMD 0.00, 95% CI -0.09 to 0.08; 9 studies; 2386 participants; moderate-certainty evidence). We are uncertain about the effect of PROMs feedback on physical functioning (14 studies; 2788 participants) and mental functioning (34 studies; 7782 participants), as well as fatigue (4 studies; 741 participants), as the certainty of the evidence was very low. We did not find studies reporting on adverse effects defined as distress following or related to PROM completion. AUTHORS' CONCLUSIONS: PROM feedback probably produces moderate improvements in communication between healthcare professionals and patients as well as in diagnosis and notation, and disease control, and small improvements to quality of life. Our confidence in the effects is limited by the risk of bias, heterogeneity and small number of trials conducted to assess outcomes of interest. It is unclear whether   many of these improvements are clinically meaningful or sustainable in the long term. There is a need for more high-quality studies in this area, particularly studies which employ cluster designs and utilise techniques to maintain allocation concealment.en_GB
dc.description.sponsorshipNational Institute for Health Research (NIHR)en_GB
dc.identifier.citationIssue 10, article CD011589en_GB
dc.identifier.doi10.1002/14651858.CD011589.pub2
dc.identifier.grantnumberNIHR/CS/010/024en_GB
dc.identifier.urihttp://hdl.handle.net/10871/127495
dc.language.isoenen_GB
dc.publisherCochrane Collaboration / Wileyen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/34637526en_GB
dc.rights.embargoreasonUnder embargo until 12 October 2022 in compliance with publisher policyen_GB
dc.rights© 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.en_GB
dc.titleRoutine provision of feedback from patient-reported outcome measurements to healthcare providers and patients in clinical practice (Review)en_GB
dc.typeArticleen_GB
dc.date.available2021-10-18T11:22:19Z
exeter.place-of-publicationEnglanden_GB
dc.descriptionThis is the final version. Available from the Cochrane Collaboration via the DOI in this recorden_GB
dc.identifier.eissn1469-493X
dc.identifier.journalCochrane Database of Systematic Reviewsen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2021
exeter.funder::National Institute for Health Research (NIHR)en_GB
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2021-10-12
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2021-10-18T11:17:56Z
refterms.versionFCDVoR
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record